Indications
Susceptible infections Cefpirome is indicated in:
Severe infections, such as septicemia, bacteremia and infections in immunosuppressed neutropenic patients with hematological malignancies
Lower respiratory infections including pneumonia
Severe urinary tract infections including pyelonephritis
Skin and soft tissue infections ... Read moreCefpirome is indicated in:
Severe infections, such as septicemia, bacteremia and infections in immunosuppressed neutropenic patients with hematological malignancies
Lower respiratory infections including pneumonia
Severe urinary tract infections including pyelonephritis
Skin and soft tissue infections
Bone and joint infections
Infections in immunocompromised patients
Other infections
Dosage And Administration
Adult: 1-2 gm every 12 hour via IV injection over 3-5 minutes or infuse over 20-30 minutes.Elderly: There are no special precautions for its use in the elderly provided dosage is adjusted accordingly to renal function.Cefpirome is administered only through the parenteral route. The dosage is dependent upon the severity and site of infection, the susceptibility of the infecting microorganisms and age, weight and renal function of the patient. The drug is administered through intravenous injection or infusion. The following dosages are recommended for moderate to severe infections in adult patients with normal renal function:
Complicated upper & lower urinary tract infections: 1 gm 12 hourly. Total daily dose not more then 2 gm
Skin & soft tissue infections: 1 gm 12 hourly. Total daily dose not more then 2 gm
Lower respiratory tract infections: 1 to 2 gm 12 hourly. Total daily dose not more then 2 to 4 gm
Bacteraemia or septicaemia and severe infections: 2 gm 12 hourly. Total daily dose not more then 4 gm
Infections in neutropenic patients: 2 gm 12 hourly. Total daily dose not more then 4 gm
Dose reduction is necessary in patients with markedly reduced renal function. After an initial dose of 0.5 -2 gm to establish a high serum concentration, the dose should be reduced by 50% for clearances of 49-21 ml/min or 75% for clearances of 20 ml/min. In end-stage renal disease, a supplementary dose equal to 50% of the recommended daily dose should be administered after each hemodialysistreatment.
Side Effects
Cefpirome is generally well tolerated. There are no predictable life threatening effects of Cefpirome. Adverse gastrointestinal reactions include diarrhea, nausea, vomiting, pseudomembraneous colitis, abdominal pain and have been noted 3.86% of the patients. Superficial phlebitis, thrombophlebitis and infection site reaction have been reported in 2.31% of patients receiving intravenous Cefpirome.
Precautions And Warnings
Allergy to penicillin or to cephalosporins; renal impairment, monitor renal and haematological status; pregnancy and lactation.
Pregnancy And Lactation
The safety of Cefpirome has not been established in pregnancy and as with all agents it should be administered with caution, especially during the early months of pregnancy. As Cefpirome is excreted in human breast milk, either Cefpirome treatment should be discontinued or breast feeding ceased.